These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36694460)

  • 41. Benefits of Less Restrictive Regulation of Advance Practice Registered Nurses in Florida.
    Unruh L; Rutherford A; Schirle L; Brunell ML
    Nurs Outlook; 2018 Nov; 66(6):539-550. PubMed ID: 30314844
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A mixed-method comparison of physician-reported beliefs about and barriers to treatment with medications for opioid use disorder.
    Haffajee RL; Andraka-Christou B; Attermann J; Cupito A; Buche J; Beck AJ
    Subst Abuse Treat Prev Policy; 2020 Sep; 15(1):69. PubMed ID: 32928272
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic contributions to alcohol use disorder treatment outcomes: a genome-wide pharmacogenomics study.
    Biernacka JM; Coombes BJ; Batzler A; Ho AM; Geske JR; Frank J; Hodgkinson C; Skime M; Colby C; Zillich L; Pozsonyiova S; Ho MF; Kiefer F; Rietschel M; Weinshilboum R; O'Malley SS; Mann K; Anton R; Goldman D; Karpyak VM
    Neuropsychopharmacology; 2021 Nov; 46(12):2132-2139. PubMed ID: 34302059
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exploring the Role of Alcohol Metabolizing Genotypes in a 12-Week Clinical Trial of Naltrexone for Alcohol Use Disorder.
    Castaldelli-Maia JM; Malbergier A; de Oliveira ABP; Amaral RA; Negrão AB; Gonçalves PD; Ventriglio A; de Berardis D; de Antonio J; Firigato I; Gattás GJF; de Toledo Gonçalves F
    Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680127
    [No Abstract]   [Full Text] [Related]  

  • 45. Prescribing patterns of buprenorphine waivered physicians.
    Thomas CP; Doyle E; Kreiner PW; Jones CM; Dubenitz J; Horan A; Stein BD
    Drug Alcohol Depend; 2017 Dec; 181():213-218. PubMed ID: 29096292
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predischarge Injectable Versus Oral Naltrexone to Improve Postdischarge Treatment Engagement Among Hospitalized Veterans with Alcohol Use Disorder: A Randomized Pilot Proof-of-Concept Study.
    Busch AC; Denduluri M; Glass J; Hetzel S; Gugnani SP; Gassman M; Krahn D; Deyo B; Brown R
    Alcohol Clin Exp Res; 2017 Jul; 41(7):1352-1360. PubMed ID: 28605827
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rates of prescription orders for United States active duty service members diagnosed with alcohol use disorder.
    Peters ZJ; Kincaid MW; Greenberg JG; Quah RF; Curry JC
    Subst Abus; 2021; 42(4):638-645. PubMed ID: 32870103
    [No Abstract]   [Full Text] [Related]  

  • 48. Advanced practice registered nurse intended actions toward patient-directed dying.
    Jannette J; DeWolf Bosek MS; Rambur B
    JONAS Healthc Law Ethics Regul; 2013; 15(2):80-8; quiz 89-90. PubMed ID: 23695352
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reward and relief dimensions of temptation to drink: construct validity and role in predicting differential benefit from acamprosate and naltrexone.
    Roos CR; Mann K; Witkiewitz K
    Addict Biol; 2017 Nov; 22(6):1528-1539. PubMed ID: 27480445
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Naltrexone: a controversial therapy for alcohol dependence.
    Freed PE; York LN
    J Psychosoc Nurs Ment Health Serv; 1997 Jul; 35(7):24-8. PubMed ID: 9243420
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A methodology for identifying behavioral health advanced practice registered nurses in administrative claims.
    Richard JV; Huskamp HA; Barnett ML; Busch AB; Mehrotra A
    Health Serv Res; 2022 Aug; 57(4):973-978. PubMed ID: 35332555
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Barriers to and Facilitators of Alcohol Use Disorder Pharmacotherapy in Primary Care: A Qualitative Study in Five VA Clinics.
    Williams EC; Achtmeyer CE; Young JP; Berger D; Curran G; Bradley KA; Richards J; Siegel MB; Ludman EJ; Lapham GT; Forehand M; Harris AHS
    J Gen Intern Med; 2018 Mar; 33(3):258-267. PubMed ID: 29086341
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characteristics and practice patterns of advanced practice registered nurses caring for older adults: A survey of Gerontological Advanced Practice Nurses Association members.
    Clevenger C; Li Y; Evans KA; Cacchione PZ
    J Am Assoc Nurse Pract; 2020 Oct; 32(10):662-667. PubMed ID: 31567837
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Naltrexone use in the treatment of alcoholism in Spain].
    Rubio Valladolid G; Espí Martínez F; Sanchís Fortea M; Bravo García De Laguna JL
    Rev Clin Esp; 2002 Aug; 202(8):435-9. PubMed ID: 12199993
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 28th Annual APRN Legislative Update: Advancements continue for APRN practice.
    Phillips SJ
    Nurse Pract; 2016 Jan; 41(1):21-48. PubMed ID: 26678422
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early adoption of injectable naltrexone for alcohol-use disorders: findings in the private-treatment sector.
    Abraham AJ; Roman PM
    J Stud Alcohol Drugs; 2010 May; 71(3):460-6. PubMed ID: 20409441
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of comorbid drug use disorder on receipt of evidence-based treatment for alcohol use disorder among VA patients with alcohol use disorder and Hepatitis C and/or HIV.
    Frost MC; Matson TE; Tsui JI; Williams EC
    Drug Alcohol Depend; 2019 Jan; 194():288-295. PubMed ID: 30469100
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Results of a National Survey: Ongoing Barriers to APRN Practice in the United States.
    Schorn MN; Myers C; Barroso J; Hande K; Hudson T; Kim J; Kleinpell R
    Policy Polit Nurs Pract; 2022 May; 23(2):118-129. PubMed ID: 35119332
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nalmefene in Alcohol Use Disorder Subjects with Psychiatric Comorbidity: A Naturalistic Study.
    Di Nicola M; De Filippis S; Martinotti G; De Risio L; Pettorruso M; De Persis S; Maremmani AGI; Maremmani I; di Giannantonio M; Janiri L
    Adv Ther; 2017 Jul; 34(7):1636-1649. PubMed ID: 28540656
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prescription drug monitoring program data tracking of opioid addiction treatment outcomes in integrated dual diagnosis care involving injectable naltrexone.
    Sajid A; Whiteman A; Bell RL; Greene MS; Engleman EA; Chambers RA
    Am J Addict; 2016 Oct; 25(7):557-64. PubMed ID: 27647699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.